StrideBio Competitors and Similar CompaniesClear all

StrideBio's competitors and similar companies include Lacerta Therapeutics, EdiGENE and Pantherna Therapeutics.
StrideBio
StrideBio
StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.
Lacerta Therapeutics
Lacerta Therapeutics
Lacerta Therapeutics is a clinical stage gene therapy company.
EdiGENE
EdiGENE
EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation).
Pantherna Therapeutics
Pantherna Therapeutics
Pantherna Therapeutics is a biopharmaceutical company engaged in the development of therapeutics for vascular diseases.
Founding Date
Founding Date
2015
Founding Date
2017
Founding Date
2015
Founding Date
2017
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
US HQ
Locations
Alachua, US HQ
Alachua, US
Locations
Cambridge, US HQ
Locations
Hennigsdorf, DE HQ
Berlin, DE
Employees
Employees
614% decrease
Employees
14
Employees
452% decrease
Employees
N/A

Funding

Latest funding round
Latest funding round
$ 81.5m (over 3 years ago)
Latest funding round
$ 30m (about 6 years ago)
Latest funding round
$ 22m (over 3 years ago)
Latest funding round
$ 3.9m (over 5 years ago)
Total funding raised
Total funding raised
$ 97.2m
Total funding raised
$ 30m
Total funding raised
$ 143.5m
Total funding raised
$ 3.9m
For sources of this data, please see the company profile

View Company Profiles

Lacerta Therapeutics
HQ
Alachua, US
Employees
14

Lacerta Therapeutics is a clinical stage gene therapy company.

View company
EdiGENE
HQ
Cambridge, US
Employees
45↓ 2% decrease

EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation).

View company
Pantherna Therapeutics
HQ
Hennigsdorf, DE

Pantherna Therapeutics is a biopharmaceutical company engaged in the development of therapeutics for vascular diseases.

View company